Real world outcomes with the use of Inotuzumab Ozogamicin in relapsed/refractory B cell acute lymphoblastic leukemia.

ABSTRACT:

SUBMITTER: Ravindranath A 

PROVIDER: S-EPMC12756246 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature